Global (United States, European Union and China) Imatinib Mesylate Drugs Market Research Report 2021-2027
- Published Date : 07-04-2021
- Pages : 110
- Report Id : 19676
- Categories : Healthcare
Imatinib is a medication used to treat cancer.
In 2021, the market size of Imatinib Mesylate Drugs is xx million US$ and it will reach xx million US$ in 2027, growing at a CAGR of xx% from 2021; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2027, with a CAGR of xx% during forecast period.
In this report, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Imatinib Mesylate Drugs.
This report studies the global market size of Imatinib Mesylate Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Imatinib Mesylate Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2021, and forecast to 2027.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2021.
In global market, the following companies are covered:
Novartis
...
Market Segment by Product Type
100mg
400mg
Market Segment by Application
Hospital
Pharmacy
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Imatinib Mesylate Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Imatinib Mesylate Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Imatinib Mesylate Drugs are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Imatinib Mesylate Drugs Market Size Growth Rate by Type (2021-2027)
1.3.2 100mg
1.3.3 400mg
1.4 Market Segment by Application
1.4.1 Global Imatinib Mesylate Drugs Market Share by Application (2021-2027)
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imatinib Mesylate Drugs Market Size
2.1.1 Global Imatinib Mesylate Drugs Revenue 2016-2027
2.1.2 Global Imatinib Mesylate Drugs Sales 2016-2027
2.2 Imatinib Mesylate Drugs Growth Rate by Regions
2.2.1 Global Imatinib Mesylate Drugs Sales by Regions 2016-2021
2.2.2 Global Imatinib Mesylate Drugs Revenue by Regions 2016-2021
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Imatinib Mesylate Drugs Sales by Manufacturers
3.1.1 Imatinib Mesylate Drugs Sales by Manufacturers 2016-2021
3.1.2 Imatinib Mesylate Drugs Sales Market Share by Manufacturers 2016-2021
3.2 Revenue by Manufacturers
3.2.1 Imatinib Mesylate Drugs Revenue by Manufacturers (2016-2021)
3.2.2 Imatinib Mesylate Drugs Revenue Share by Manufacturers (2016-2021)
3.2.3 Global Imatinib Mesylate Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Imatinib Mesylate Drugs Price by Manufacturers
3.4 Key Manufacturers Imatinib Mesylate Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Imatinib Mesylate Drugs Market
3.6 Key Manufacturers Imatinib Mesylate Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 100mg Sales and Revenue (2016-2021)
4.1.2 400mg Sales and Revenue (2016-2021)
4.2 Global Imatinib Mesylate Drugs Sales Market Share by Type
4.3 Global Imatinib Mesylate Drugs Revenue Market Share by Type
4.4 Imatinib Mesylate Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Imatinib Mesylate Drugs Sales by Application
6 United States
6.1 United States Imatinib Mesylate Drugs Breakdown Data by Company
6.2 United States Imatinib Mesylate Drugs Breakdown Data by Type
6.3 United States Imatinib Mesylate Drugs Breakdown Data by Application
7 European Union
7.1 European Union Imatinib Mesylate Drugs Breakdown Data by Company
7.2 European Union Imatinib Mesylate Drugs Breakdown Data by Type
7.3 European Union Imatinib Mesylate Drugs Breakdown Data by Application
8 China
8.1 China Imatinib Mesylate Drugs Breakdown Data by Company
8.2 China Imatinib Mesylate Drugs Breakdown Data by Type
8.3 China Imatinib Mesylate Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Imatinib Mesylate Drugs Breakdown Data by Company
9.2 Rest of World Imatinib Mesylate Drugs Breakdown Data by Type
9.3 Rest of World Imatinib Mesylate Drugs Breakdown Data by Application
9.4 Rest of World Imatinib Mesylate Drugs Breakdown Data by Countries
9.4.1 Rest of World Imatinib Mesylate Drugs Sales by Countries
9.4.2 Rest of World Imatinib Mesylate Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Imatinib Mesylate Drugs
10.1.4 Imatinib Mesylate Drugs Product Introduction
10.1.5 Novartis Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Imatinib Mesylate Drugs Sales Channels
11.2.2 Imatinib Mesylate Drugs Distributors
11.3 Imatinib Mesylate Drugs Customers
12 Market Forecast
12.1 Global Imatinib Mesylate Drugs Sales and Revenue Forecast 2021-2027
12.2 Global Imatinib Mesylate Drugs Sales Forecast by Type
12.3 Global Imatinib Mesylate Drugs Sales Forecast by Application
12.4 Imatinib Mesylate Drugs Forecast by Regions
12.4.1 Global Imatinib Mesylate Drugs Sales Forecast by Regions 2021-2027
12.4.2 Global Imatinib Mesylate Drugs Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Imatinib Mesylate Drugs Product Picture
Table Imatinib Mesylate Drugs Key Market Segments
Table Major Manufacturers Imatinib Mesylate Drugs Covered in This Report
Table Global Imatinib Mesylate Drugs Market Size Growth Rate by Type 2021-2027 (K Units) & (Million US$)
Figure Global Imatinib Mesylate Drugs Sales Market Shar by Type 2016-2027
Figure 100mg Figures
Table Major Manufacturers of 100mg
Figure 400mg Figures
Table Major Manufacturers of 400mg
Table Global Imatinib Mesylate Drugs Market Share by Application 2021-2027 (K Units)
Figure Hospital Use Case
Figure Pharmacy Use Case
Figure Imatinib Mesylate Drugs Report Years Considered
Figure Global Imatinib Mesylate Drugs Market Size 2016-2027 (Million US$)
Figure Global Imatinib Mesylate Drugs Sales 2016-2021 (K Units)
Table Global Imatinib Mesylate Drugs Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global Imatinib Mesylate Drugs Sales by Regions 2016-2021 (K Units)
Table Global Imatinib Mesylate Drugs Sales Market Share by Regions 2016-2021
Figure Global Imatinib Mesylate Drugs Sales Market Share by Regions 2016-2021
Figure Global Imatinib Mesylate Drugs Sales Market Share by Regions in 2019
Table Global Imatinib Mesylate Drugs Revenue by Regions 2016-2021 (Million US$)
Table Global Imatinib Mesylate Drugs Revenue Market Share by Regions 2016-2021
Figure Global Imatinib Mesylate Drugs Revenue Market Share by Regions 2016-2021
Figure Global Imatinib Mesylate Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Imatinib Mesylate Drugs Sales by Manufacturers (2016-2021) (K Units)
Table Global Imatinib Mesylate Drugs Sales Share by Manufacturers (2016-2021)
Figure Global Imatinib Mesylate Drugs Sales Share by Manufacturers in 2019
Table Imatinib Mesylate Drugs Revenue by Manufacturers (2016-2021) (Million USD)
Table Imatinib Mesylate Drugs Revenue Share by Manufacturers (2016-2021)
Figure Imatinib Mesylate Drugs Value Share by Manufacturers in 2019
Table Global Imatinib Mesylate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Imatinib Mesylate Drugs Price (2016-2021) (USD/Unit)
Table Key Manufacturers Imatinib Mesylate Drugs Plants/Factories Distribution
Table Key Manufacturers Imatinib Mesylate Drugs Area Served
Table Date of Key Manufacturers Enter into Imatinib Mesylate Drugs Market
Table Key Manufacturers Imatinib Mesylate Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 100mg Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global 400mg Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Imatinib Mesylate Drugs Sales by Type (2016-2021) (K Units)
Table Global Imatinib Mesylate Drugs Sales Share by Type (2016-2021)
Figure Global Imatinib Mesylate Drugs Sales Market Share by Type (2016-2021)
Figure Global Imatinib Mesylate Drugs Sales Market Share by Type in 2020
Table Global Imatinib Mesylate Drugs Revenue by Type (2016-2021) (Million US$)
Table Global Imatinib Mesylate Drugs Revenue Share by Type (2016-2021)
Figure Global Imatinib Mesylate Drugs Revenue Market Share by Type (2016-2021)
Figure Global Imatinib Mesylate Drugs Revenue Market Share by Type in 2020
Table Imatinib Mesylate Drugs Price by Type 2016-2021 (USD/Unit)
Table Global Imatinib Mesylate Drugs Sales by Application (2016-2021) (K Units)
Table Global Imatinib Mesylate Drugs Sales Share by Application (2016-2021)
Figure Global Sales Imatinib Mesylate Drugs Market Share by Application (2016-2021)
Figure Global Sales Imatinib Mesylate Drugs Market Share by Application (2016-2021)
Figure United States Imatinib Mesylate Drugs Sales Growth Rate 2016-2021 (K Units)
Figure United States Imatinib Mesylate Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table United States Imatinib Mesylate Drugs Sales by Company (2016-2021) (K Units)
Table United States Imatinib Mesylate Drugs Sales Market Share by Company (2016-2021)
Figure United States Imatinib Mesylate Drugs Sales Market Share by Company in 2019
Table United States Imatinib Mesylate Drugs Sales by Type (2016-2021) (K Units)
Table United States Imatinib Mesylate Drugs Sales Market Share by Type (2016-2021)
Figure United States Imatinib Mesylate Drugs Market Share by Type in 2019
Table United States Imatinib Mesylate Drugs Sales by Application (2016-2021) (K Units)
Table United States Imatinib Mesylate Drugs Sales Market Share by Application (2016-2021)
Figure United States Imatinib Mesylate Drugs Market Share by Application in 2019
Figure European Union Imatinib Mesylate Drugs Sales Growth Rate 2016-2021 (K Units)
Figure European Union Imatinib Mesylate Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table European Union Imatinib Mesylate Drugs Sales by Company (2016-2021) (K Units)
Table European Union Imatinib Mesylate Drugs Sales Market Share by Company (2016-2021)
Figure European Union Imatinib Mesylate Drugs Sales Market Share by Company in 2019
Table European Union Imatinib Mesylate Drugs Sales by Type (2016-2021) (K Units)
Table European Union Imatinib Mesylate Drugs Sales Market Share by Type (2016-2021)
Figure 2020 European Union Imatinib Mesylate Drugs Market Share by Type
Table European Union Imatinib Mesylate Drugs Sales by Application (2016-2021) (K Units)
Table European Union Imatinib Mesylate Drugs Sales Market Share by Application (2016-2021)
Figure 2020 European Union Imatinib Mesylate Drugs Market Share by Application
Figure China Imatinib Mesylate Drugs Sales Growth Rate 2016-2021 (K Units)
Figure China Imatinib Mesylate Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table China Imatinib Mesylate Drugs Sales by Company (2016-2021) (K Units)
Table China Imatinib Mesylate Drugs Sales Market Share by Company (2016-2021)
Figure China Imatinib Mesylate Drugs Sales Market Share by Company in 2019
Table China Imatinib Mesylate Drugs Sales by Type (2016-2021) (K Units)
Table China Imatinib Mesylate Drugs Sales Market Share by Type (2016-2021)
Figure China Imatinib Mesylate Drugs Market Share by Type in 2019
Table China Imatinib Mesylate Drugs Sales by Application (2016-2021) (K Units)
Table China Imatinib Mesylate Drugs Sales Market Share by Application (2016-2021)
Figure China Imatinib Mesylate Drugs Market Share by Application in 2019
Figure Rest of World Imatinib Mesylate Drugs Sales Growth Rate 2016-2021 (K Units)
Figure Rest of World Imatinib Mesylate Drugs Revenue Growth Rate 2016-2021 (Million US$)
Table Rest of World Imatinib Mesylate Drugs Sales by Company (2016-2021) (K Units)
Table Rest of World Imatinib Mesylate Drugs Sales Market Share by Company (2016-2021)
Figure Rest of World Imatinib Mesylate Drugs Sales Market Share by Company in 2019
Table Rest of World Imatinib Mesylate Drugs Sales by Type (2016-2021) (K Units)
Table Rest of World Imatinib Mesylate Drugs Sales Market Share by Type (2016-2021)
Figure Rest of World Imatinib Mesylate Drugs Market Share by Type in 2019
Table Rest of World Imatinib Mesylate Drugs Sales by Application (2016-2021) (K Units)
Table Rest of World Imatinib Mesylate Drugs Sales Market Share by Application (2016-2021)
Figure Rest of World Imatinib Mesylate Drugs Market Share by Application in 2019
Table Rest of World Imatinib Mesylate Drugs Sales by Countries (2016-2021) (K Units)
Table Rest of World Imatinib Mesylate Drugs Sales Market Share by Countries (2016-2021)
Figure Rest of World Imatinib Mesylate Drugs Sales Market Share by Countries in 2019
Table Rest of World Imatinib Mesylate Drugs Revenue by Countries (2016-2021) (Million US$)
Table Rest of World Imatinib Mesylate Drugs Revenue Market Share by Countries (2016-2021)
Figure Rest of World Imatinib Mesylate Drugs Revenue Market Share by Countries in 2019
Figure Japan Imatinib Mesylate Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Japan Imatinib Mesylate Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure Korea Imatinib Mesylate Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Korea Imatinib Mesylate Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure India Imatinib Mesylate Drugs Sales Growth Rate (2016-2021) (K Units)
Figure India Imatinib Mesylate Drugs Revenue Growth Rate (2016-2021) (K Units)
Figure Southeast Asia Imatinib Mesylate Drugs Sales Growth Rate (2016-2021) (K Units)
Figure Southeast Asia Imatinib Mesylate Drugs Revenue Growth Rate (2016-2021) (K Units)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Imatinib Mesylate Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Novartis Imatinib Mesylate Drugs Sales Growth Rate (2016-2021)
Table Novartis Imatinib Mesylate Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Figure Imatinib Mesylate Drugs Value Chain
Table Imatinib Mesylate Drugs Distributors List
Table Imatinib Mesylate Drugs Customers List
Table Global Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units) & (Million US$)
Figure Global Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Table Global Imatinib Mesylate Drugs Sales Forecast by Type 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Forecast by Type 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Market Share Forecast by Type 2021-2027
Table Global Imatinib Mesylate Drugs Sales Forecast by Application 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Forecast by Application 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Market Share Forecast by Application 2021-2027
Table Global Imatinib Mesylate Drugs Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Sales Market Share Forecast by Regions 2021-2027
Table Global Imatinib Mesylate Drugs Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Imatinib Mesylate Drugs Revenue Market Share Forecast by Regions 2021-2027
Figure United States Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure United States Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure European Union Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure European Union Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure China Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure China Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Japan Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure Japan Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Korea Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure Korea Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure India Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure India Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Imatinib Mesylate Drugs Sales Forecast 2021-2027 (K Units)
Figure Southeast Asia Imatinib Mesylate Drugs Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied ™ Copyright © 2025 .